These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32589994)

  • 1. In Reply to Ghadjar et al.
    Wang Y; Chen H
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):856. PubMed ID: 32589994
    [No Abstract]   [Full Text] [Related]  

  • 2. In Reply to Ghadjar et al.
    Pisansky TM; Tendulkar RD
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):439-440. PubMed ID: 28068253
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to P. Ghadjar et al.
    Roy S; Malone S
    J Clin Oncol; 2020 May; 38(15):1747-1748. PubMed ID: 32209004
    [No Abstract]   [Full Text] [Related]  

  • 4. In Regard to Wang et al.
    Ghadjar P; Beck M; Zschaeck S; Wust P
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):855. PubMed ID: 32589993
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to V.G. Gupta et al and W. Zou et al.
    Gupta S; Maheshwari A; Parab P
    J Clin Oncol; 2018 Sep; 36(27):2813-2814. PubMed ID: 29897828
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31.
    Nabid A; Souhami L
    Eur Urol; 2019 Mar; 75(3):e63. PubMed ID: 30773206
    [No Abstract]   [Full Text] [Related]  

  • 7. In reply to Xie et al.
    Vargo JA; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):475-6. PubMed ID: 25968828
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Pirus Ghadjar, Thomas Wiegel's Letter to the Editor re: Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome, Toxicity of Stereotactic Body Radiotherapy, Elective Nodal Radiotherapy. Eur Urol 2019;76:732-9.
    De Bleser E; Ost P
    Eur Urol; 2020 Mar; 77(3):e62-e63. PubMed ID: 31744645
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer.
    Harima Y; Ohguri T; Imada H; Sakurai H; Ohno T; Hiraki Y; Tuji K; Tanaka M; Terashima H
    Int J Hyperthermia; 2016 Nov; 32(7):801-8. PubMed ID: 27418208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Reply to Govardhan et al.
    Ferrandina G
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):213-4. PubMed ID: 26279040
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial.
    Ohguri T; Harima Y; Imada H; Sakurai H; Ohno T; Hiraki Y; Tuji K; Tanaka M; Terashima H
    Int J Hyperthermia; 2018 Jun; 34(4):461-468. PubMed ID: 28679349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation.
    Heijkoop ST; van Doorn HC; Stalpers LJ; Boere IA; van der Velden J; Franckena M; Westermann AM
    Int J Hyperthermia; 2014 Feb; 30(1):6-10. PubMed ID: 24156619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to T. Seisen et al and P. Ghadjar et al.
    Tendulkar RD; Agrawal S; Pisansky TM
    J Clin Oncol; 2017 May; 35(13):1491-1492. PubMed ID: 28135134
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial.
    Minnaar CA; Kotzen JA; Ayeni OA; Naidoo T; Tunmer M; Sharma V; Vangu MD; Baeyens A
    PLoS One; 2019; 14(6):e0217894. PubMed ID: 31216321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy--a phase III study.
    Zolciak-Siwinska A; Piotrkowicz N; Jonska-Gmyrek J; Nicke-Psikuta M; Michalski W; Kawczyńska M; Bijok M; Bujko K
    Radiother Oncol; 2013 Nov; 109(2):194-9. PubMed ID: 23684588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of treatment duration during concomitant chemoradiation therapy for cervical cancer. In regard to Shaverdian et al.
    Hintz B
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):633-4. PubMed ID: 24138909
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic models for locally advanced cervical cancer: external validation of the published models.
    Lora D; Gómez de la Cámara A; Fernández SP; Enríquez de Salamanca R; Gómez JFPR
    J Gynecol Oncol; 2017 Sep; 28(5):e58. PubMed ID: 28657220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of the hyperthermia treatment planning system HyperPlan to predict effectiveness and toxicity.
    Sreenivasa G; Gellermann J; Rau B; Nadobny J; Schlag P; Deuflhard P; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):407-19. PubMed ID: 12527054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoradioresistance of the female reproductive system cancer--can local laser hyperthermia contribute to its overcoming?].
    Titova VA; Shevchenko LN; Kreinina YM; Petrovsky VY
    Vopr Onkol; 2015; 61(4):661-6. PubMed ID: 26571841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concurrent chemoradiotherapy (CCRT) in uterine cervical cancer].
    Toita T
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():255-9. PubMed ID: 23156252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.